Bioconjugate Chemistry
Article
synthesis and transfection efficiencies of pyridinium-based
cationic lipids with glutamide as the backbone.21 In the design
of cationic lipids, linkers are used to connect the headgroup
or the hydrophobic portion to the backbone, for example,
glycerol.22−24 This is to provide biodegradability and thereby
safety due to decreased toxicities. Ester linkages are preferred
over ether linkers25 primarily for their biodegradability. In some
reports, the linkers are designed to enhance the release of the
nucleic acid from the lipoplex in response to a change in
conditions inside the cell. For example, low pH labile bonds
are used to dissociate the headgroup from the lipid in the
endosomal compartment and release the plasmid DNA.13
Reduction of linkers with disulfide bonds in the cytoplasmic
milieu destabilizes the complex26 thereby separating the nucleic
acid from the liposomes. Recently, in an otherwise chemically
similar lipid, the linker orientation was shown to have dramatic
effect on the transfection properties of the lipid.24 We report in
this study two lysinated-glutamide lipids which differ from each
other only in their linker chemistry, i.e., either amide or an ester
designated as Lipid 1 and Lipid 2, respectively. Lipid 1 with an
amide linker melts at a higher temperature and has higher
transfection efficiency than the low melting counterpart Lipid
2 with the ester linker. This striking structural difference
between the two lipids motivated further investigations to
address whether the linker has any role in determining the
transfection efficiency.
CH2CH2NH), 1.62 (m, 2H, CHCH2(CH2)3NH), 1.83 (q, 2H,
CH3OC(O)C*HCH2), 3.08−3.18 (m, 4H, C*H-
(CH2)3CH2NHC(O)), 3.68 (s, 3H, CH3), 4.18 (s, 1H,
CH3OC(O)C*H), 4.53 (s, 1H, NHC(O)C*HNHC(
O)), 5.07 (m, 6H, C*H2Ph), 7.35 (d, 15H, C6H5). Anal.
Found: H, 6.77%; C, 63.4%; N, 7.97%. Calcd. for C37H46N4O9:
H, 6.71%; C, 64.3%; N, 8.11%.
(B). Z-Lys(Z)-Lys(Z)-OH. Z-Lys(Z)-Lys(Z)-OMe (4.6 g, 6.60
mmol) and 1 N NaOH 19 mL (19 mmol) were dissolved in
100 mL methanol, stirred for 1 h at room temperature, and pH
was adjusted to 2 by 1 N HCl. After removing methanol from
the solution in vacuo, the residue was added to ethanol. The
obtained white precipitate was removed by filtration, and the
solution was concentrated and added to n-hexane to give a
white precipitate. The precipitate was collected by filtration and
dried in vacuo: yield 4.30 g (95% 6.35 mmol) mp 145−147 °C;
FT-IR (KBr) 3322, 2941, 2863, 1692, 1652, and 1541 cm−1; 1H
NMR (CDCl3) δ 1.35 (m, 4H, C*HCH2CH2), 1.47 (m, 4H,
CH2CH2NH), 1.63−1.86 (br, 4H, C*HCH2), 3.10 (d, 4H,
C*H(CH2)3CH2NHC(O)), 4.26 (s, 1H, HOC(O)C*H),
4.50 (s, 1H, NHC(O)C*HNHC(O)), 5.06 (m, 6H, CH2Ph),
7.29 (d, 15H, C6H5). Anal. Found: H, 6.86%; C, 63.44%; N, 8.08%.
Calcd. for C36H44N4O9: H, 6.55%; C, 63.9%; N, 8.28%.
Synthesis of Lipid 1 (2C12-Gln-Lys-Lys). (A). Synthesis of
2C12-Gln. Synthesis of 2C12-Gln was described earlier (Bio-
conjugate Chem. 2006, 17, 1530).
(B). 2C12-Gln-Lys(Z)-Lys(Z)-Z. 2C12-Gln (0.93 g, 1.93
mmol), Z-Lys(Z)-Lys(Z)-OH (1.30 g, 1.92 mmol), and
triethylamine (0.37 g, 3.84 mmol) were dissolved in dry THF
(100 mL). The solution was cooled to 0 °C, and DEPC (0.52 g,
2.88 mmol) was added to the solution and stirred for 1 day at
room temperature. After stirring, the solution was concentrated
in vacuo, and the lipid was recrystallized from ethanol, which
gave a white solid powder: yield 1.07 g (50%, 0.94 mmol); mp
184−187 °C; FT-IR (KBr) 3295, 2925, 2853, 1693, 1637, and
1543 cm−1; 1H NMR (CDCl3) δ 0.86−0.89 (t, 6H, CH3), 1.25
(m, 36H, CH3(CH2)9), 1.33 (s, 4H, CH2CH2NHC(O)),
1.48 (br, 6H, C*H(CH2)NHC(O)), 1.58−2.40 (s, 8H,
C*HCH2CH2CH2, C*HCH2CH2CH2), 2.44 (m, 2H,
C*HCH2CH2C(O)), 3.16−3.23 (br, 8H, CH2NHC(O),
CH2NHC(O)O), 4.11 (s, 1H, C*HNHC(O)), 4.35 (s,
1H, C*HNHC(O)), 4.51 (s, 1H, C*HNHC(O)), 4.92−
5.15 (br, 6H, CH2Ph) 7.28−7.34 (m, 15H, C6H5). Anal. Found:
H, 8.94%; C, 68.3%; N, 8.56%; Calcd. for C65H101N7O10: H,
8.93%; C, 68.5%; N, 8.60%.
EXPERIMENTAL PROCEDURES
■
Materials. In this work, all chemicals and solvents were
purchased and used without further purification. The chemical
structures of the lipids were identified by melting point, FTIR,
1H NMR, and elemental analysis. Melting points were deter-
mined on a micro melting point apparatus. FTIR spectra were
1
performed on a JASCO FT/IR-4000 spectrometer. H NMR
spectra were recorded by a JEOL JNM-EX400 spec-
trometer using tetramethylsilane as an internal standard.
Elemental analyses were performed with a Yanaco CHN
Corder MT-3. ESI-HRMS was performed on a QSTAR XL
hybrid MS/MS system (Applied Biosystems/MDS sciex),
equipped with an ESI source.
1,6-diphenyl-1,3,5-hexatriene, ethidium bromide, NBD-
DHPE, and Rhodamine −DHPE were purchased from Molecular
Probes (USA). 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine
(DOPE), cholesterol, L-α-phosphatidylglycerol (PG), and 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC) were purchased
from Avanti Polar Lipids (USA). Fluorescein (FAM) Labeling
Kits were sourced from Ambion. 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) and other reagents
were purchased from Sigma Co.
(C). 2C12-Gln-Lys-Lys. 2C12-Gln-Lys(Z)-Lys(Z)-Z (0.93 g,
0.82 mmol) was dissolved in 100 mL ethanol with heating, and
Pd/carbon (0.5 g) was added to the solution. H2 gas was
bubbled slowly into the solution for 14 h at 70 °C. Pd/carbon
was removed by filtration, and the solution was dried in vacuo
to give a solid powder: yield 0.34 g (52%, 0.43 mmol, as
a trihydrate); mp 104−107 °C; FT-IR (KBr) 3289, 2920,
Synthesis of Z-Lys(Z)-Lys(Z)-OH. (A). Z-Lys(Z)-Lys(Z)-
OMe. Z-Lys(Z)-OH (3.42 g, 9.06 mmol), H-Lys(Z)-
OMe·HCl (3.0 g, 9.06 mmol), and triethylamine (2.76 g,
27.1 mmol) were dissolved in chloroform. The solution was
cooled to 0 °C, and DEPC (1.97 g, 1.09 mmol) was added to
the solution and stirred for 30 min at this temperature. After
stirring for 1 day at room temperature, the solution was con-
centrated in vacuo, and the residue was dissolved in chloroform.
The solution was washed with 0.2 N HCl, 5 wt % NaHCO3,
and water. The solution was dried over Na2SO4, concentrated,
and finally added to diethyl ether, which gave a white solid
powder: yield 4.56 g (73%, 6.5 mmol); mp 103−105 °C; FT-IR
1
2851, 1639, and 1557 cm−1; H NMR (CDCl3) δ 0.87−0.90
(t, 6H, CH3), 1.28 (m, 36H, CH3(CH2)9), 1.52−2.17 (br, 20H,
CH2CHNHC(O), CH2C*H, CH2CH2C*H, CH2(CH2)2C*H),
3.12−3.35 (br, 8H, CH2-NHC(O), CH2NHC(CO)O),
4.31−4.56 (br, 3H, C*HNHC(O)). Anal. Found: H, 10.9%;
C, 64.9%; N, 11.4%. Calcd. for C41H89N7O7: H, 11.3%; C,
62.2%; N, 12.4%. ESI-HRMS: m/z = +738.6569 (calcd value for
C41H84N7O4 = 738.6584).
Synthesis of Lipid 2 (2C12Glu-Lys-Lys). (A). Didodecyl-
L-Glutamate Toluene-p-Sulfonate (2C12L-Glu TosOH).
L-Glutamic acid (6.0 g, 40.0 mmol), p-toluenesulfonic acid
(KBr) 3316, 2942, 1741, 1690, 1650, and 1542 cm−1; H
NMR (CDCl3) δ 1.37 (m, 4H, C*HCH2CH2), 1.49 (m, 4H,
1
2245
dx.doi.org/10.1021/bc2002874|Bioconjugate Chem. 2011, 22, 2244−2254